Clincosm LogoSign in Get a demo

recurrent head and neck cancer

Showing 1 - 14 of 14
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Head Neck Cancer, Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Carcinoma Trial in Saint

Not yet recruiting
  • Recurrent Head and Neck Cancer
  • +5 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 30, 2023

Recurrent Head Neck Cancer, Local Cryotherapy Treatment Trial in Strasbourg (local cryotherapy treatment)

Not yet recruiting
  • Recurrent Head and Neck Cancer
  • Local Cryotherapy Treatment
  • local cryotherapy treatment
  • Strasbourg, France
    Hôpitaux Universitaires de Strasbourg
Feb 20, 2023

Metastatic Head Neck Cancer, Recurrent Head Neck Cancer Trial in Worldwide (Bempegaldesleukin, Pembrolizumab)

Terminated
Has Results
  • Metastatic Head and Neck Cancer
  • Recurrent Head and Neck Cancer
  • Omaha, Nebraska
  • +3 more
Dec 16, 2022

Unresectable Head and Neck Squamous Cell Carcinoma, Metastatic Head Neck Cancer, Recurrent Head Neck Cancer Trial in Worldwide

Recruiting
  • Unresectable Head and Neck Squamous Cell Carcinoma
  • +2 more
  • BNT113
  • Pembrolizumab
  • Los Angeles, California
  • +79 more
Jan 9, 2023

Recurrent Head Neck Cancer, Head Neck Cancer, Head and Neck Tumors Trial in Cincinnati (Durvalumab, Cetuximab)

Active, not recruiting
  • Recurrent Head and Neck Cancer
  • +3 more
  • Cincinnati, Ohio
    UC Health
Oct 3, 2022

Recurrent Head Neck Cancer, Metastatic Head Neck Cancer Trial (Pembrolizumab, Cisplatin, Carboplatin)

Active, not recruiting
Has Results
  • Recurrent Head and Neck Cancer
  • Metastatic Head and Neck Cancer
  • Pembrolizumab
  • +4 more
  • (no location specified)
Aug 18, 2022

Recurrent Head Neck Cancer, Carcinoma, Squamous Cell of Head and Neck Trial in Baltimore, Philadelphia, Pittsburgh

Recruiting
  • Recurrent Head and Neck Cancer
  • Carcinoma, Squamous Cell of Head and Neck
  • Baltimore, Maryland
  • +3 more
Mar 25, 2022

Metastatic Head Neck Cancer, Recurrent Head Neck Cancer Trial in United States (ADU-S100)

Terminated
Has Results
  • Metastatic Head and Neck Cancer
  • Recurrent Head and Neck Cancer
  • Birmingham, Alabama
  • +16 more
Dec 3, 2021

Transoral Robotic Surgery for rECurrent Tumours of Upper

Recruiting
  • Recurrent Head and Neck Cancer
    • London, Greater London, United Kingdom
    • +1 more
    Oct 1, 2021

    Recurrent Head Neck Cancer, Metastatic Head Neck Cancer Trial (Mitoxantrone Hydrochloride Liposome, intravenous injection (IV))

    Not yet recruiting
    • Recurrent Head and Neck Cancer
    • Metastatic Head and Neck Cancer
    • Mitoxantrone Hydrochloride Liposome, intravenous injection (IV)
    • (no location specified)
    May 20, 2021

    Metastatic Solid Tumor Cancer, Recurrent Head Neck Cancer Trial in Houston (Ad-P53, Xeloda, Keytruda)

    Terminated
    • Metastatic Solid Tumor Cancer
    • Recurrent Head and Neck Cancer
    • Houston, Texas
      MD Anderson Cancer Center
    May 30, 2020

    Recurrent Head Neck Cancer Trial in United States (PIT: 50 J/cm^2 for superficial lesions or 100 J/cm for interstitial lesions

    Completed
    • Recurrent Head and Neck Cancer
    • PIT: 50 J/cm^2 for superficial lesions or 100 J/cm for interstitial lesions and Drug RM-1929: 160 mg/m^2
    • +5 more
    • San Francisco, California
    • +6 more
    Feb 20, 2020

    Recurrent Head Neck Cancer, Metastatic Head Neck Cancer Trial in Boston (docetaxel, , gefitinib)

    Terminated
    Has Results
    • Recurrent Head and Neck Cancer
    • Metastatic Head and Neck Cancer
    • Boston, Massachusetts
      Eastern Cooperative Oncology Group
    Apr 21, 2015

    Recurrent Head Neck Cancer Trial in Denver (IPI-926 and Cetuximab)

    Completed
    • Recurrent Head and Neck Cancer
    • IPI-926 and Cetuximab
    • Denver, Colorado
      University of Colorado Denver
    Jan 29, 2014